158 related articles for article (PubMed ID: 16357124)
1. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
Kaneda A; Feinberg AP
Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
Hassan AB; Howell JA
Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
[TBL] [Abstract][Full Text] [Related]
3. Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.
Harper J; Burns JL; Foulstone EJ; Pignatelli M; Zaina S; Hassan AB
Cancer Res; 2006 Feb; 66(4):1940-8. PubMed ID: 16488992
[TBL] [Abstract][Full Text] [Related]
4. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
6. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
[TBL] [Abstract][Full Text] [Related]
7. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.
Cui H; Cruz-Correa M; Giardiello FM; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Powe NR; Feinberg AP
Science; 2003 Mar; 299(5613):1753-5. PubMed ID: 12637750
[TBL] [Abstract][Full Text] [Related]
8. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.
Cui H; Horon IL; Ohlsson R; Hamilton SR; Feinberg AP
Nat Med; 1998 Nov; 4(11):1276-80. PubMed ID: 9809551
[TBL] [Abstract][Full Text] [Related]
10. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus.
Waterland RA; Lin JR; Smith CA; Jirtle RL
Hum Mol Genet; 2006 Mar; 15(5):705-16. PubMed ID: 16421170
[TBL] [Abstract][Full Text] [Related]
11. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
12. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
Brown KW; Power F; Moore B; Charles AK; Malik KT
Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
[TBL] [Abstract][Full Text] [Related]
13. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
[TBL] [Abstract][Full Text] [Related]
15. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.
Sakatani T; Kaneda A; Iacobuzio-Donahue CA; Carter MG; de Boom Witzel S; Okano H; Ko MS; Ohlsson R; Longo DL; Feinberg AP
Science; 2005 Mar; 307(5717):1976-8. PubMed ID: 15731405
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.
Kaneda A; Wang CJ; Cheong R; Timp W; Onyango P; Wen B; Iacobuzio-Donahue CA; Ohlsson R; Andraos R; Pearson MA; Sharov AA; Longo DL; Ko MS; Levchenko A; Feinberg AP
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20926-31. PubMed ID: 18087038
[TBL] [Abstract][Full Text] [Related]
18. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
Xu W; Fan H; He X; Zhang J; Xie W
J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
[TBL] [Abstract][Full Text] [Related]
19. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
